Dyne Therapeutics · 2 hours ago
Director, Medical Information
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Director, Medical Information is responsible for establishing and leading the medical information function to ensure timely, accurate, and compliant scientific responses to inquiries from healthcare professionals.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Establish and lead the medical information function, including strategy, processes, and execution
Establish scalable medical information infrastructure, including inquiry intake, documentation, and response workflows
Oversee the implementation and training of the medical inquiry intake portal and call center vendors and manage relationships going forward
Develop high-quality medical information response documents (standard response letters, FAQs, backgrounders) and maintain medical information content aligned with product labeling, clinical data, and evolving scientific evidence
Ensure responses are scientifically accurate, balanced, up-to-date, and compliant with regulations
Ensure appropriate escalation and coordination of safety, quality, and off-label inquiries
Analyze inquiry trends to identify knowledge gaps, unmet medical needs, and opportunities to inform medical strategy
Monitor metrics and quality indicators to ensure continuous improvement and compliance
Qualification
Required
Doctorate degree (MD, PhD, PharmD) with 10+ years of experience in medical information or medical affairs in rare diseases, neuromuscular diseases, or a related field
Strong understanding of regulatory, compliance, and pharmacovigilance requirements
Excellent scientific writing and verbal communication skills
Strong organizational and process-building capabilities
High attention to detail and commitment to compliance and scientific integrity
Ability to work effectively in a matrixed, fast-paced biotech environment
Strong judgment in handling complex or sensitive inquiries
Preferred
Experience establishing or leading a medical information function is strongly preferred
Company
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.67BKey Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M
Recent News
2026-01-11
2026-01-07
2025-12-24
Company data provided by crunchbase